Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 9OTHER 5OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5Sarcoma 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Sarcoma, Myeloid 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × vosaroxin × Clear all
NCT02658487 2025-04-15

VITAL

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
42 enrolled 12 charts
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

NCT01893320 2022-02-09

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

M.D. Anderson Cancer Center

Phase 1/2 Completed
66 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03338348 2020-10-28

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

University of Ulm

Phase 2 Completed
9 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02272478 2020-01-23

AML18

Cardiff University

Phase 2/3 Unknown
1,600 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02485353 2017-09-20

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Indiana University

Phase NA Terminated
2 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡